96712 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being basic
Sub-classes:AMINO ACID-MODIFIED LIPIDS FOR RNA DELIVERY
#2TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#3PROCESS FOR MANUFACTURING MACROCYCLIC PEPTIDES
#4AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#5AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#6TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#7SUBSTITUTION OF HISTIDINE WITH 2-THIOHISTIDINE IN BIOACTIVE PEPTIDES
#8Cyanine Dyes
#9TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS
#10MITOCHONDRIA-TARGETING PEPTIDES
#11Mitochondria-targeting peptides
#12MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#13Peptide macrocycles against
#14Inhibitors of IAP
#15INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#16Transfection complexes and methods of using the same
#17PEPTIDE INHIBITING ACTIVITY OF ARYL HYDROCARBON RECEPTOR AND COSMETIC COMPOSITION USING SAME
#18PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#19TRANSITION METAL CHELATING BEADS
#20METHODS OF TREATING OSTEONECROSIS WITH LLP2A-BISPHOSPHONATE COMPOUNDS
#21AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#22Bifunctional cytotoxic agents containing the CTI pharmacophore
#23OLIGOPEPTIDE HAVING DENGUE VIRUS REPLICATION INHIBITION FUNCTION AND APPLICATION THEREOF
#24Aromatic-cationic peptides and uses of same
#25Compositions comprising cyclic peptides derived from an A-beta peptide
#26PEPTIDE COMPOSITIONS AND RELATED METHODS
#27PEPTIDE COMPOSITIONS AND RELATED METHODS
#28Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#29Cyanine dyes
#30Peptide inhibitors of tight junction permeability
#31Peptide macrocycles and use thereof in the treatment of bacterial infections
#32Anti-bacterial peptide macrocycles and use thereof
#33Interferon Analogs
#34Peptide macrocycles against
#35Inhibitors of IAP
#36Peptide, composition comprising said peptide and uses thereof, in particular cosmetic uses
#37Anti-inflammatory tripeptides
#38Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#39AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#40THERAPEUTIC COMPOSITIONS INCLUDING PHENAZINE-3-ONE AND PHENOTHIAZINE-3-ONE DERIVATIVES AND USES THEREOF
#41Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
#42Difluoroketamide derivatives as HtrA1 inhibitors
#43AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#44Peptide macrocycles against Acinetobacter baumannii
#45Transfection complexes and methods of using the same
#46Interferon analogs
#47Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting
#48Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#49Inhibition of gliadin peptides
#50NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#51Inhibitors of growth factor activation enzymes
#52Bis-alkoxyl amide alkyl cationic peptide lipids, synthesis method thereof, and application thereof
#53CANCER IMAGING AGENT
#54Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
#55Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
#56Self-assembling tripeptides
#57Peptide macrocycles against acinetobacter baumannii
#58Compositions and methods for treating colorectal cancer
#59Antibacterial agents
#60Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#61Cyanine dyes
#62Trapping reagents for reactive metabolites screening
#63Cleavage and exchange of major histocompatibility complex ligands employing azobenzene-containing peptides
#64INHIBITION OF GLIADIN PEPTIDES
#65Macrocyclic broad spectrum antibiotics
#66Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#67Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
#68AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#69Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptides
#70Interferon Analogs
#71Human cytomegalovirus neutralising antibodies and use thereof
#72ASSAY FOR INSULIN-DEGRADING ENZYME (IDE) INHIBITORS
#73Storage stable lyophilized tripeptide formulations
#74Bifunctional cytotoxic agents containing the CTI pharmacophore
#75Anti-inflammatory tripeptides
#76HCV protease inhibitors and uses thereof
#77NOVEL INHIBITORS OF MAMMALIAN TIGHT JUNCTION OPENING
#78Process for the manufacture of degarelix and its intermediates
#79Secondary structure stabilized NMDA receptor modulators and uses thereof
#80Inhibitors of IAP
#81Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
#82Functionalized cyanine dyes (PEG)
#83Anti-inflammatory proteins and peptides and methods of preparation and use thereof
#84Conformations of divergent peptides with mineral binding affinity
#85Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#86Scaffold-based polymerase enzyme substrates
#87IAP antagonists
#88INHIBITION OF GLIADIN PEPTIDES
#89Phospholinked dye analogs with an amino acid linker
#90Compositions comprising enzyme-cleavable oxycodone prodrug
#91Peptides and use thereof
#92Substrates and inhibitors of prolyl oligopeptidase and methods of use
#93Inflammation inhibiting compounds
#94Short antimicrobial lipopeptides
#95Cyanine dyes
#96Tyrosine based linkers for the releasable connection of peptides
#97Compositions containing delta-9-THC-amino acid esters and process of preparation
#98Conformations of divergent peptides with mineral binding affinity
#99Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
#100Tripeptide KDPT for antiapoptotic treatment
#101Cyclin Based Inhibitors of CDK2 and CDK4
#102Inhibitors of IAP
#103Peptide-based peroxidase inhibitors and methods of using same
#104Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#105Peptide for use in the treatment of skin conditions
#106NUCLEIC ACID BINDING COMPOUNDS, METHODS OF MAKING, AND USE THEREOF
#107Process for the manufacture of Degarelix and its intermediates
#108Inhibitors of IAP
#109Human cytomegalovirus neutralising antibodies and use thereof
#110Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#111High-Affinity Peptide Probes for Tumor Biomarker, GRP-78, and Screening Method Thereof
#112Interferon analogs
#113AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#114Secondary structure stabilized NMDA receptor modulators and uses thereof
#115C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#116HCV protease inhibitors and uses thereof
#117Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
#118SERINE HYDROLASE FORMULATION
#119Selective poly-substituted glycine antibiotics and related compositions
#120Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#121Conformations of divergent peptides with mineral binding affinity
#122Age inhibitors
#123Compositions comprising enzyme-cleavable oxycodone prodrug
#124Composition
#125PROCESS FOR THE PURIFICATION OF HUMAN GROWTH HORMONE POLYPEPTIDES USING AFFINITY RESINS COMPRISING SPECIFIC LIGANDS
#126Scaffold-based polymerase enzyme substrates
#127Human cytomegalovirus neutralising antibodies and use thereof
#128Method of treatment of bacterial infection by administration of poly-lysine
#129Functionalized cyanine dyes (PEG)
#130Molecular adaptors for dye conjugates
#131Functionalized cyanine dyes (PEG)
#132Phospholinked dye analogs with an amino acid linker
#133Cyanine dyes
#134Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#135Inflammation inhibiting compounds
#136Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses
#137G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#138Means and methods for manufacturing highly pure neurotoxin
#139Cysteine-free efficient Technetium (Tc) or Rhenium (Re) chelating peptide tags and their use
#140Peptidic compounds
#141N-terminally modified tetrapeptide derivatives having a C-terminal arginine mimetic
#142Inhibition of gliadin peptides
#143METHODS AND SYSTEMS TO DETECT AN ACTIVE PROTEASE IN A SAMPLE
#144Method of treatment of non-dermatophytic fungal infections
#145Oligomeric biosurfactants in dermatocosmetic compositions
#146PEPTIDE VACCINE FOR INFLUENZA VIRUS
#147Antimicrobial compounds
#148Inhibitors of mammalian tight junction opening
#149Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders
#150Polypeptides KXK and their use
#151Method of treatment of a fungal infection with poly arginine peptides
#152PROBE COMPOUNDS FOR PROTEIN TYROSINE PHOSPHATASE (PTP) AND PRECURSORS THEREOF
#153BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#154Reagent for introduction of protein or gene
#155COMPOSITIONS FOR REDUCING OXIDATIVE STRESS AND USES THEREOF
#156Nucleic acid binding compounds and methods of use
#157PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#158D-amino acid peptides
#159Transfection complexes
#160Antimicrobial and anticancer lipopeptides
#161METHOD FOR SYNTHESIZING KPV TRIPEPTIDE DIAMIDE DERIVATES
#162NOVEL SMALL MOLECULE DNAK INHIBITORS
#163PEPTIDE VACCINE FOR INFLUENZA VIRUS
#164HCV protease inhibitors and uses thereof
#165HCV protease inhibitors and uses thereof
#166Selective poly-N-substituted glycine antibiotics
#167INHIBITION OF ALPHA-SYNUCLEIN AGGREGATION
#168Liquid phase peptide synthesis of KL-4 pulmonary surfactant
#169Plasma protein-binding ligands
#170Selective substrates for matrix metalloproteinases
#171Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#172Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof
#173OLIGOPEPTIDES FOR USE AS TASTE MODULATORS
#174NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#175Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
#176Peptide derivatives useful as antimicrobial agents and for treating wounds
#177Topical application agents against mimic and age-related wrinkles
#178Peptide, pharmaceutical composition, and a method of treating microcirculation disorders
#179Human cytomegalovirus neutralising antibodies and use thereof
#180HCV NS3 protease inhibitors
#181Amide forming chemical ligation
#182Transfection complexes
#183Composite material useful as biomaterial and its preparation
#184Antibody Binding Affinity Ligands
#185Peptidic compounds
#186PEPTIDES AND PEPTIDE MIMETICS TO TREAT PATHOLOGIES CHARACTERIZED BY AN INFLAMMATORY RESPONSE
#187C-Met receptor regulation by angiotensin IV (AT) receptor ligands
#188Age Inhibitors
#189Biologically active peptides and their use for repairing injured nerves
#190Peptide antibiotics and methods for making same
#191Plasma protein-binding ligands
#192Hepatitis C virus inhibitors
#193Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#194ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#195Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide
#196Methods for treatment of a dermatophytic fungal infection
#197α-MSH-antagonist dipeptide conjugates
#198Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
#199Liquid phase peptide syntheses of KL-4 pulmonary surfactant
#200D-amino acid peptides
#201Stabilizing peptides
#202Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#203Histone H2A peptide derivatives and uses thereof
#204Hepatitis C virus inhibitors
#205Antimicrobial and anticancer lipopeptides
#206Amide forming chemical ligation
#207Orally administered small peptides synergize statin activity
#208Peptidic conjugates for alopecia prevention and treatment
#209Peptides promoting cell adherence, growth and secretion
#210G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
#211Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
#212Alpha-4 beta-1 integrin ligands for imaging and therapy
#213Liquid phase peptide synthesis of KL-4 pulmonary surfactant
#214Peptide antibiotics and peptide intermediates for their prepartion
#215Methods of inhibiting glutamate receptors by administering the tripeptide KDI
#216Methods for identifying RNA binding compounds
#217Di-, tri-, and tetra-peptides having antiangiogenic activity
#218Selective substrates for matrix metalloproteinases
#219Orally administered small peptides synergize statin activity
#220Use of KPV tripeptide for dermatological disorders
#221Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#222Pharmaceutical/cosmetic compositions comprising the lysine-D-proline-valine tripeptide
#223Sunburn treatment and sunburn prevention method
#224D-amino acid peptides
#225Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof